A network of four research platforms in West Africa tracks the health of roughly 240,000 people, collecting data on births, deaths, and migration to calculate community mortality and birth rates. This matters because high-quality medical research in low-resource settings depends on reliable infrastructure that most people never see. Without stable platforms to identify patients, store biological samples, manage data, and run clinical trials, studies on diseases such as tuberculosis and malaria cannot happen. The Tuberculosis Case Contact platform, for example, follows confirmed TB patients and their household contacts for two years to measure infection risk—a basic question that requires sustained, organised effort to answer. If these platforms continue to function, they enable world-class clinical research in West Africa that would otherwise be impossible. The laboratory services, biobank, and clinical trial support allow investigators to conduct studies funded by multiple donors. This is primarily infrastructure for fundamental and applied science. It does not produce a single breakthrough, but it makes every subsequent discovery possible—much as a reliable power grid makes a factory run. The real impact is invisible: better data, cleaner samples, and trials that actually finish on time.
View original technical description
Research Platforms and Cohorts An important proportion of research activities funded by a variety of donors is supported by research platforms, research services and professional services, mostly funded by MRC core funding. There are 4 platforms. The health and demographic surveillance system cover a population of about 240,000 and collects data on births, deaths, immigration and emigration that allow estimating birth and mortality rates in the communities. The West Africa platform supports collaborative links with other West African institutions. The Clinical Research platform includes the MRCG clinical services and other Government health facilities, including the University Hospital, in which clinical studies and trials are carried out. The Tuberculosis Case Contact platform (TBCC) identifies TB-confirmed cases and their household contacts, and follow them for 2 years to determine the risk of TB infection and disease. Research Services Research services provide support to investigators. They are divided in two clusters, namely the research governance and support services (RGSS) and the laboratory services (LAB). The RGSS includes clinical trial support, data management and statistics, research development and project management. Its activities go from the negotiation of contracts to implementation of clinical trials. The LAB includes all laboratory activities, plus the biobank and the biomedical engineering. This services are essential to carry out high-quality, world-class research.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know